Corrigendum to Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? [Intern Med J 45, (2015), 55-62], doi:10.1111/imj.12627;Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?

Internal Medicine Journal

Volumn 45, Issue 1, 2015, Pages 55-62

  Diasinos, N ^a   Baysari, M ^a,b   Kumar, S ^a   Day, R O ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Computerised dose prediction; Decision support; Gentamicin; Interviews; Therapeutic drug monitoring

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DRUG DOSE REGIMEN; DRUG MONITORING; ELECTRONIC PRESCRIBING; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL DECISION MAKING; MIDDLE AGED; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; SEMI STRUCTURED INTERVIEW; SHORT COURSE THERAPY; VERY ELDERLY; YOUNG ADULT; CLINICAL PRACTICE; CLINICAL TRIAL; DOSE RESPONSE; FOLLOW UP; GRAM-NEGATIVE BACTERIAL INFECTIONS; MORBIDITY; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; TRENDS;

AGED; ANTI-BACTERIAL AGENTS; DECISION SUPPORT SYSTEMS, CLINICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; GENTAMICINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NEW SOUTH WALES; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 84920964256     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12751     Document Type: Erratum

References (24)

1. Falagas M, Grammatikos A, Michalopoulos A. Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 2008; 6: 593-600.
2. van Maarseveen E, van Buul-Gast MC, Abdoellakhan R, Gelinck L, Neef C, Touw D. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients. J Antimicrob Chemother 2014; 69: 2581-2583.
3. Munckhof W, Grayson M, Turnidge J. A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemoth 1996; 37: 645-663.
4. Ali M, Goetz M. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 796-809.
5. Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24: 786-795.
6. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996; 312: 338-344.
7. Kirkpatrick C, Duffull S, Begg E. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharm 1999; 47: 637-643.
8. Boyer A, Gruson D, Bouchet S, Clouzeau B, Hoang-Nam B, Vargas F etal. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk. Drug Safety 2013; 36: 217-230.
9. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic (Version 12). Melbourne: Therapeutic Guidelines Limited; 2010.
10. Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME. Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 2011; 71: 2277-2294.
11. Avent ML, Teoh J, Lees J, Eckert KA, Kirkpatrick CM. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia. Ther Drug Monit 2011; 33: 592-601.
12. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic (Version 14). Melbourne: Therapeutic Guidelines Limited; 2010.
13. Matthews I, Kirkpatrick C, Holford N. Quantitative justification for target concentration intervention-parameter variability and predictive performance using population pharmacokinetic models for gentamicin. Br J Clin Pharm 2004; 58: 8-19.
14. Martin J, Barras M, Ah Yui N, Kirkpatrick C, Kubler P, Norris R. Gentamicin monitoring practices in teaching hospitals-time to undertake the necessary randomised controlled trial. J Clin Toxicol 2012; 2: 146-151.
15. Leong CL, Buising K, Richards M, Robertson M, Street A. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital. Intern Med J 2006; 36: 37-42.
16. Mohan M, Batty KT, Cooper JA, Wojnar-Horton RE, Ilett KF. Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: antibiotic' nomogram and the SeBA-GEN and DoseCalc software programs. Br J Clin Pharmacol 2004; 58: 521-527.
17. Smyth J, Yeung M. Targeting gentamicin therapeutic ranges during the first week of life in infants in neonatal intensive care. Aust J Hosp Pharm 2001; 31: 291-294.
18. Briggs D, Howes L, Edwards C. Gentamicin usage and monitoring in a Sydney teaching hospital. Aust J Hosp Pharm 1997; 27: 133-135.
19. Johnston CF, Carroll PR, Matthews ST, Mitchell SJ, Hilmer SN. 'You look like a 240mg': gentamicin dosing at a Sydney hospital. J Pharm Pract Res 2011; 41: 275-277.
20. Baysari MT, Tang T, Brett J, Day RO. Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'. J Pharm Pract Res 2012; 42: 178-179.
21. Patton M. Qualitative Evaluation and Research Methods, 3rd edn. NewBury Park, CA: Sage Publications Inc; 2001.
22. Slaughter R, Cappelletty D. Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring. Pharmacoeconomics 1998; 14: 385-394.
23. van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13: 138-147.
24. Baysari MT, Westbrook JI, Richardson KL, Day RO. The influence of computerized decision support on prescribing during ward-rounds: are the decision-makers targeted? J Am Med Inform Assoc 2011; 18: 754-759.